Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 9 results.
User Information
Export Records
  1. 1.   Inflammation-induced loss of Pdcd4 is mediated by phosphorylation-dependent degradation
  2. Schmid, T.; Bajer, M. M.; Blees, J. S.; Eifler, L. K.; Milke, L.; Rubsamen, D.; Schulz, K.; Weigert, A.; Baker, A. R.; Colburn, N. H.; Brune, B.
  3. Carcinogenesis. 2011, Oct; 32(10): 1427-1433.
  1. 2.   Downregulation of Programmed Cell Death 4 by Inflammatory Conditions Contributes to the Generation of the Tumor Promoting Microenvironment
  2. Yasuda, M.; Schmid, T.; Rubsamen, D.; Colburn, N. H.; Irie, K.; Murakami, A.
  3. Molecular Carcinogenesis. 2010, Sep; 49(9): 837-848.
  1. 3.   Nuclear Accumulation of beta-Catenin Protein Indicates Activation of wnt Signaling in Chemically Induced Rat Nephroblastomas
  2. Ehrlich, D.; Bruder, E.; Thome, M. A.; Gutt, C. N.; Doeberitz, M. V.; Niggli, F.; Perantoni, A. O.; Koesters, R.
  3. Pediatric and Developmental Pathology. 2010, Jan-Feb; 13(1): 1-8.
  1. 4.   Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow
  2. Salcedo, R.; Hixon, J. A.; Stauffer, J. K.; Jalah, R.; Brooks, A. D.; Khan, T.; Dai, R. M.; Scheetz, L.; Lincoln, E.; Back, T. C.; Powell, D.; Hurwitz, A. A.; Sayers, T. J.; Kastelein, R.; Pavlakis, G. N.; Felber, B. K.; Trinchieri, G.; Wigginton, J.
  3. Journal of Immunology. 2009 182(7): 4328-4338.
  1. 5.   Linoleic acid metabolite suppresses skin inflammation and tumor promotion in mice: possible roles of programmed cell death 4 induction
  2. Yasuda, M.; Nishizawa, T.; Ohigashi, H.; Tanaka, T.; Hou, D. X.; Colburn, N. H.; Murakami, A.
  3. Carcinogenesis. 2009 30(7): 1209-1216.
  1. 6.   Cytotoxicity of RH1: NAD(P)H : quinone acceptor oxidoreductase (NQO1)-independent oxidative stress and apoptosis induction
  2. Tudor, G.; Alley, M.; Nelson, C. M.; Huang, R. L.; Covell, D. G.; Gutierrez, P.; Sausville, E. A.
  3. Anti-Cancer Drugs. 2005 16(4): 381-391.
  1. 7.   Components of the cell death machine and drug sensitivity of the National Cancer Institute cell line panel
  2. Svingen, P. A.; Loegering, D.; Rodriquez, J.; Meng, X. W.; Mesner, P. W.; Holbeck, S.; Monks, A.; Krajewski, S.; Scudiero, D. A.; Sausville, E. A.; Reed, J. C.; Lazebnik, Y. A.; Kaufmann, S. H.
  3. Clinical Cancer Research. 2004, OCT 15; 10(20): 6807-6820.
  1. 8.   Induction of transplantable mouse renal cell cancers by streptozotocin: In vivo growth, metastases, and angiogenic phenotype
  2. Gruys, M. E.; Back, T. C.; Subleski, J.; Wiltrout, T. A.; Lee, J. K.; Schmidt, L.; Watanabe, M.; Stanyon, R.; Ward, J. M.; Wigginton, J. M.; Wiltrout, R. H.
  3. Cancer Research. 2001 61(16): 6255-6263.
  1. 9.   mdr1 promoter-driven tumor necrosis factor-alpha expression for a chemotherapy-controllable combined in vivo gene therapy and chemotherapy of tumors
  2. Walther, W.; Stein, U.; Fichtner, I.; Alexander, M.; Shoemaker, R. H.; Schlag, P. M.
  3. Cancer Gene Therapy. 2000 7(6): 893-900.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel